Comparison MiNK Therapeutics (INKT) with Competitors
MiNK Therapeutics (INKT) industry is Biotechnology.
Free Cash Flow Yield
INKT-11.87%
Industry-1.75%
Upside-10.13%
P/E
INKT-3.72
Industry-20.52
Upside+1680.02%
P/B
INKT11.33
Industry5.15
Upside+120.14%